SREBF2 and homozygous familial hypercholesterolemia: This study thus uncovered a liver‐peripheral crosstalk mediated by SREBP2‐ANGPTL3 axis and suggests that SREBP2 inhibition could be an effective strategy to tackle homozygous familial hypercholesterolemia (HoFH).